Ana Vidović
Impact in
- Hematology top 2%
- Acute Myeloid Leukemia Research
- Multiple Myeloma Research and Treatments
- Platelet Disorders and Treatments
- Genetics top 5%
- Myeloproliferative Neoplasms: Diagnosis and Treatment
Papers in
- Hematology 46
- Acute Myeloid Leukemia Research 30
- Multiple Myeloma Research and Treatments 13
- Platelet Disorders and Treatments 7
-
- Retinoids in leukemia and cellular processes 8
- Co-authors
- Nada Suvajdžić (36 shared papers)Dragica Tomin (26 shared papers)Irena Đjunić (22 shared papers)Nataša Čolović (24 shared papers)Ivo Elezović (12 shared papers)Marijana Virijević (26 shared papers)Mirjana Mitrović (16 shared papers)Gradimir Janković (12 shared papers)
- Journals
- Medical Oncology (9 papers)Biomedicine & Pharmacotherapy (5 papers)Platelets (2 papers)Cancers (2 papers)HemaSphere (2 papers)
- Partner nations
- SerbiaUnited StatesRussia
In The Last Decade
Ana Vidović
63 papers receiving 572 citations
Peers
Comparison fields: 5 of 74
- Hematology 406
- Genetics 165
- Equine 24
- Internal Medicine 29
- Biochemistry 26
Countries citing papers authored by Ana Vidović
This map shows the geographic impact of Ana Vidović's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ana Vidović with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ana Vidović more than expected).
Fields of papers citing papers by Ana Vidović
This network shows the impact of papers produced by Ana Vidović. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ana Vidović. The network helps show where Ana Vidović may publish in the future.
Co-authors
The 25 scholars most cited alongside Ana Vidović, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 74 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2012 | 70 | |
| 2 | 2014 | 46 | |
| 3 | 2014 | 31 | |
| 4 | 1995 | 31 | |
| 5 | 2000 | 26 | |
| 6 | 2010 | 26 | |
| 7 | 2012 | 22 | |
| 8 | 2017 | 21 | |
| 9 | 2008 | 21 | |
| 10 | 2011 | 20 | |
| 11 | 2016 | 16 | |
| 12 | 1999 | 14 | |
| 13 | 2013 | 14 | |
| 14 | 2011 | 12 | |
| 15 | 2013 | 12 | |
| 16 | 2012 | 11 | |
| 17 | 2013 | 11 | |
| 18 | 2012 | 11 | |
| 19 | 2012 | 9 | |
| 20 | 2012 | 9 |
About Ana Vidović
Ana Vidović is a scholar working on Hematology, Molecular Biology, Genetics, Oncology and Public Health, Environmental and Occupational Health, having authored 74 papers that have together received 585 indexed citations. Recurring topics across this work include Acute Myeloid Leukemia Research (30 papers), Myeloproliferative Neoplasms: Diagnosis and Treatment (13 papers), Multiple Myeloma Research and Treatments (13 papers), Acute Lymphoblastic Leukemia research (11 papers), Retinoids in leukemia and cellular processes (8 papers), Lymphoma Diagnosis and Treatment (7 papers), Platelet Disorders and Treatments (7 papers) and Hematological disorders and diagnostics (5 papers). The work is most often cited by research in Hematology (406 citations), Genetics (165 citations), Equine (24 citations), Internal Medicine (29 citations) and Biochemistry (26 citations). Ana Vidović has collaborated with scholars based in Serbia, United States and Russia. Frequent co-authors include Nada Suvajdžić, Dragica Tomin, Irena Đjunić, Nataša Čolović, Ivo Elezović, Marijana Virijević, Mirjana Mitrović, Gradimir Janković, Milica C̆olović and Darko Antić. Their work appears in journals such as Medical Oncology, Biomedicine & Pharmacotherapy, Platelets, Cancers and HemaSphere.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.